The evolving concept of tumor microenvironments

BioEssays

Volumn 29, Issue 8, 2007, Pages 738-744

  Laconi, Ezio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDOSIS; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CELL TRANSFORMATION; EVOLUTION; GENETIC STABILITY; HUMAN; MICROENVIRONMENT; NONHUMAN; REVIEW; STROMA CELL; TUMOR CELL; TUMOR GROWTH;

CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; PRECANCEROUS CONDITIONS; STROMAL CELLS;

EID: 34547640147     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20606     Document Type: Review

References (84)

1. Paget S. 1889. The distribution of secondary growths in cancer of the breast. Lancet 1:571-573.
2. Mintz B, Illmensee K. 1975. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72:3585-3589.
3. Prehn RT. 1964. A clonal selection theory of chemical carcinogenesis. J Natl Cancer Inst 32:1-17.
4. Solt DB, Farber E. 1976. A new principle for the analysis of chemical carcinogenesis. Nature 263:702-703.
5. Laconi E, Pani P, Farber E. 2000. The resistance phenotype in the development and treatment of cancer. Lancet Oncol 1:235-241.
6. Strickland JE, Ueda M, Hennings H, Yuspa SH. 1992. A model for initiated mouse skin: suppression of cells in grafts on athymic nude mice. Cancer Res 52:1439-1444.
7. Alt-Holland A, Zhang W, Margulis A, Garlick J. 2005. Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Sem Cancer Biol 15:84-96.
8. Brush DE. 1997. Sunlight and the onset of skin cancer. Trends Genet 13:410-414.
9. Zhang W, Remenyik E, Zelterman D, Brash D, Wikonkal NM. 2001. Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci USA 98:13948-13953.
10. Mudgil AV, Segal N, Andriani F, Wang Y, Fusenig NE, et al. 2003. Ultraviolet B irradiation induces expansion of intraepithelial tumor cells in a tissue model of early cancer progression. J Invest Dermatol 121:191-197.
11. Bachman KE, Sager J, Cheong I, Catto M, Bardelli A, et al. 2005. Identification of compounds that inhibit the growth of 2-amino-1-methyl- 6phenylimidazo(4,5-b)pyridine-resistant cancer cells. Mol Cancer Ther 4:1026-1030.
12. Laconi S, Pani P, Pillai S, Pasciu D, Sarma DSR, et al. 2001. A growth constrained environment drives tumor progression in vivo. Proc Natl Acad Sci USA 98:7806-7811.
13. Rubin H. 2006. What keeps cells in tissues behaving normally in the face of myriad mutations? ByoEssays 28:515-524.
14. Laconi S, Pillai S, Porcu PP, Shafritz DA, Pani P, et al. 2001. Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol 158:771-777.
15. Laconi E. 2000. Differential growth: from carcinogenesis to liver repopulation. Am J Pathol 156:389-392.
16. Omory Y, Zaidan Dagli ML, Yamakage K, Yamasaki H. 2001. Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice. Mutat Res 477:191-196.
17. Smalley KSM, Brafford PA, Herlyn M. 2005. Selective evolutionary pressure from the tissue microenvironment drives tumor progression. Sem Cancer Biol 15:451-459.
18. Balducci L, Ershler WB. 2005. Cancer and aging: a nexus at several levels. Nat Rev Cancer 5:655-662.
19. Rubin H. 2001. The role of selection in progressive neoplastic transformation. Adv Cancer Res 83:159-207.
20. Pasciu D, Montisci S, Greco M, Doratiotto S, Pitzalis S, et al. 2006. Aging is associated with increased clonogenic potential in rat liver in vivo. Aging Cell 5:373-377.
21. McCullough KD, Coleman WB, Smith GJ, Grisham JW. 1994. Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. Cancer Res 54:3668-3671.
22. Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, et al. 2002. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16:935-942.
23. Farber E, Rubin H. 1991. Cellular adaptation in the origin and development of cancer. Cancer Res 51:2751-2761.
24. Nelson CM, Bissel MJ. 2006. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287-309.
25. Mueller MM, Fusenig NE. 2004. Friends or foes - Bipolar effects of the tumor stroma in cancer. Nat Rev Cancer 4:839-849.
26. Praia DA, Kuperwasser C. 2005. Stroma - Tumor agonist or antagonist. Cell Cycle 4:1022-1025.
27. Barcellos-Hoff MH, Ravani SA. 2000. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60:1254-1260.
28. Barcellos-Hoff MH. 2005. Integrative radiation carcinogenesis: interactions between cell and tissue response to DNA damage. Sem Cancer Biol 15:138-148.
29. Tsai KKC, Chuang EY-Y, Little JB, Yuan Z-M. 2005. Cellular mechanisms for low dose ionizing radiation-induced perturbation of the breast tissue microenvironment. Cancer Res 65:6734-6744.
30. Greenberger J, Epperly M, Zeevi A, Brunson K, Goltry K, et al. 1996. Stromal cell involvement in leukemogenesis and carcinogenesis. In Vivo 10:11-17.
31. Kuperwasser C, Chavarria T, Wu M, Megrane G, Gray JW, et al. 2004. Reconstruction of functionally normal and malignant human breast tissue in mice. Proc Natl Acad Sci USA 101:4966-4971.
32. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A, Kalofoutis A. 2005. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65:1627-1630.
33. Parrinello S, Coppe J-P, Krtolica A, Campisi J. 2005. Stroma-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118:485-496.
34. Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S, et al. 2006. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66:794-802.
35. Tlsty TD, Hein PW. 2001. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Gen Dev 11:54-59.
36. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. 2004. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 117:1495-1502.
37. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Gray JW, et al. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137-146.
38. Bhowmick NA, Chytil A, Plieth D, Dumont N, Shappel S, et al. 2004. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-851.
39. Moinfar F, Man YG, Arnould L, Bratthauer L, Ratschek M, et al. 2000. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60:2562-2566.
40. Weber F, Shen L, Fukino K, Patocs A, Mutter GL, et al. 2006. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies stroma as a potential landscaper for neoplastic initiation. Am J Human Gen 78:961-972.
41. Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu T. 2006. Epithelial and stromal genetic instability contributes to the genesis of colorectal adenomas. Gut 55:695-702.
42. Fischer AH, Young KA, DeLellis RA. 2004. Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development. J Cell Biochem 93:28-36.
43. Soto A, Sonnenschein C. 2005. The somatic mutation theory of cancer: growing problems with a paradigm? BioEssays 26:1097-1107.
44. Capp J-P. 2005. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development. BioEssays 27:1277-1285.
45. Sonnenschein C, Soto A. 2006. Carcinogenesis and metastasis now in the third dimension - what's in for the pathologists? Am J Pathol 168: 363-366.
46. Folkman IJ. 2003. Fundamental concepts of the angiogenic process. Curr Mol Med 3:643-651.
47. Gatenby RA, Gillies RJ. 2004. Why do cancers have high aerobic glycolysis. Nat Rev Cancer 4:891-899.
48. Gatenby RA, Frieden BR. 2004. Information dynamics in carcinogenesis and tumor growth. Mutat Res 568:259-273.
49. Crespi B, Summers K. 2005. Evolutionary biology of cancer. Trends Ecol Evol 20:545-552.
50. Bindra RS, Glazer PM. 2005. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res 569:75-78.
51. Fantin VR, St-Pierre J, Leder P. 2006. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425-434.
52. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
53. Reynolds TY, Rockwell S, Glazer PM. 1996. Genetic instability induced by the tumor microenvironment. Cancer Res 56:5754-5757.
54. Yuan J, Narayanan L, Rockwell S, Glazer PM. 2000. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 60:4372-4376.
55. Li CY, Little JB, Hu K, Zhang W, Zhang L, et al. 2001. Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res 61:428-432.
56. Papp-Szabo E, Josephy PD, Coomber BL. 2005. Mioroenvironmental influences on mutagenesis in mammary epithelial cells. Int J Cancer 116:679-685.
57. Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M. 1998. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell 2:259-265.
58. Hida K, Hida Y, Amin DN, Flint AF, Panigray D, et al. 2004. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64:8249-8255.
59. Hida K, Klagsbrun M. 2005. A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. Cancer Res 65:2507-2510.
60. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, et al. 2003. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347-361.
61. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. 2006. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66: 5216-5223.
62. Sivridis E, Giatromanolaki A, Koukourakis MI. 2005. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol 58:1033-1038.
63. Semenza GL, Wang GL. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454.
64. Potter C, Harris AL. 2004. Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survival pathway and therapy target. Cell Cycle 3:164-167.
65. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, et al. 2002. Hypoxia-inducible-factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62:3387-3394.
66. Koshiji M, To KK, Hammer S, Kumamoto K, Harris AL, et al. 2005. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell 17:793-803.
67. Bindra RS, Crosby ME, Glazer PM. 2007. Regulation of DNA repair in hypoxic cancer cells. Cancer Metast Rev Apr 6; [Epub ahead of print].
68. Foster PL. 2005. Stress responses and genetic variation in bacteria. Mut Res 569:3-11.
69. Yeiser B, Pepper ED, Goodman MF, Finkel SE. 2002. SOS-induced DNA polymarases enhance long-term survival and evolutionary fitness. Proc Natl Acad Sci USA 99:8737-8741.
70. Wang J, Kawamura K, Tada Y, Ohmori H, Kimura H, et al. 2001. DNA polymerase κ, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res 61:5366-5369.
71. Yang J, Chen Z, Liu Y, Hickey RJ, Malkas LH. 2004. Altered DNA polymerase ι expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res 64:5597-5607.
72. Littlepage LE, Egeblad M, Werb Z. 2005. Coevolution of cancer and stromal cellular responses. Cancer Cell 7:499-500.
73. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/ CXCL12 secretion. Cell 121:335-348.
74. Melillo G, Semenza GL. 2006. Meeting report: Exploiting the tumor microenvironment for therapeutics. Cancer Res 66:4558-4560.
75. Albini A, Sporn MB. 2007. The tumor microenvironment as a target for chemoprevention. Nat Rev Cancer AOP publ Online January 12. 76. Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, et al. 2001. International Cooperative Study Group on Hepatocellular Carcinoma. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 136: 528-535.
76. Buhler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, et al. 1982. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 82:775-782.
77. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AHFM, et al. 2005. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436:660-665.
78. Chen Z, Trotman LC, Shaffer D, Lin H-K, Dotan ZA, et al. 2005. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725-730.
79. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, et al. 2005. Senescence in premalignant tumors. Nature 436:642.
80. Michaloglou C, Vredeveld LCW, Soengas MS, Denoyelle C, Kuilman T, et al. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-724.
81. Sharpless NE, DePinho RA. 2005. Crime and punishment. Nature 436: 636-637.
82. Braig M, Schmitt CA. 2006. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 66:2881-2884.
83. Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, et al. 2001. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 276:7919-7926.
84. Hammond EM, Gree SL, Giacoia AJ. 2003. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat Res 532:205-213.